A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in the Netherlands-Reference-Cited by-同舟云学术

A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in the Netherlands

Published:2003-02 Issue:2 Volume:25 Page:635-646
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

van Hout Ben A.,Klok Rogier M.,Brouwers Jacobus R.B.J.,Postma Maarten J.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference43 articles.

1. ABC of the upper gastrointestinal tract. Management of Helicobacter pylori infection;Harris;BMJ,2001

2. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis;Chiba;Gastroenterology,1997

3. Continued utilization and costs of proton pump inhibitors after Helicobacter pylori eradication in chronic users of gastrointestinal drugs;Klok;Aliment Pharmacol Ther,2002

4. Randomized controlled trial of omeprazole or endoscopy in patients with persistent dyspepsia: A cost-effectiveness analysis;Laheij;Aliment Pharmacol Ther,1998

5. Prescriptions for antiulcer drugs in Australia: Volume, trends, and costs;Westbrook;BMJ,2001

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a particle swarm optimization-backpropagation artificial neural network model and effects of age and gender on pharmacokinetics study of omeprazole enteric-coated tablets in Chinese population;BMC Pharmacology and Toxicology;2022-07-19

2. Pharmacists’ considerations on non-medical switching at the hospital: a systematic review of the economic outcomes of cost-saving therapeutic drug classes;European Journal of Hospital Pharmacy;2021-01-20

3. Initial proton pump inhibitor characteristics associated with long-term prescriptions in US veterans diagnosed with gastro-oesophageal reflux disease;Journal of Pharmaceutical Health Services Research;2014-05-22

4. Therapeutic management of uncomplicated gastroesophageal reflux disease in france in 2005: Potential cost savings of omeprazole substitution;Current Therapeutic Research;2009-08

5. Étude pharmaco-économique sur la prise en charge du reflux gastro-œsophagien en France en 2005 en médecine générale;La Presse Médicale;2008-10